TCIM
AERI

TIAA CREF Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

TIAA CREF Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5.53M Sell
116,506
-4,525
-4% -$199K ﹤0.01% 1375
2018
Q4 		$4.37M Sell
121,031
-2,683
-2% -$126K ﹤0.01% 1465
2018
Q3 		$7.62M Buy
123,714
+39,014
+46% +$2.51M 0.01% 1286
2018
Q2 		$5.72M Sell
84,700
-5,692
-6% -$318K ﹤0.01% 1502
2018
Q1 		$4.9M Buy
90,392
+996
+1% +$55.7K ﹤0.01% 1565
2017
Q4 		$5.34M Sell
89,396
-11,001
-11% -$667K ﹤0.01% 1563
2017
Q3 		$4.88M Sell
100,397
-23,841
-19% -$1.3M ﹤0.01% 1641
2017
Q2 		$6.53M Buy
124,238
+9,781
+9% +$455K ﹤0.01% 1414
2017
Q1 		$5.19M Sell
114,457
-6,289
-5% -$280K ﹤0.01% 1575
2016
Q4 		$4.57M Buy
120,746
+7,531
+7% +$285K ﹤0.01% 1661
2016
Q3 		$4.27K Buy
113,215
+10,759
+11% +$237K ﹤0.01% 1708
2016
Q2 		$1.8M Buy
102,456
+747
+0.7% +$12.1K ﹤0.01% 2183
2016
Q1 		$1.24M Sell
101,709
-2,190
-2% -$34.7K ﹤0.01% 2356
2015
Q4 		$2.53M Sell
103,899
-6,619
-6% -$154K ﹤0.01% 2011
2015
Q3 		$1.96M Buy
110,518
+21,577
+24% +$391K ﹤0.01% 2153
2015
Q2 		$1.57M Buy
88,941
+48,959
+122% +$898K ﹤0.01% 2451
2015
Q1 		$1.25M Sell
39,982
-1,779
-4% -$51.6K ﹤0.01% 2492
2014
Q4 		$1.22M Sell
41,761
-2,708
-6% -$68.7K ﹤0.01% 2542
2014
Q3 		$920K Buy
44,469
+6,700
+18% +$132K ﹤0.01% 2677
2014
Q2 		$936K Buy
37,769
+11,800
+45% +$204K ﹤0.01% 2756
2014
Q1 		$550K Buy
25,969
+5,900
+29% +$119K ﹤0.01% 2912
2013
Q4 		$360K Buy
+20,069
New +$261K ﹤0.01% 3027

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

TIAA CREF Investment Management's AERI Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Aerie Pharmaceuticals (AERI) stake by 3.7% in Q1 2019, selling an estimated $199K and leaving 116,506 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

TIAA CREF Investment Management first reported a position in AERI in Q4 2013 and has held it in 22 quarters since. The position peaked at $7.62M in Q3 2018. 176 funds tracked by Wall St. Rank hold AERI as of Q1 2019.

  • TIAA CREF Investment Management held 116,506 shares of Aerie Pharmaceuticals worth $5.53M as of Q1 2019.
  • TIAA CREF Investment Management sold 4,525 Aerie Pharmaceuticals shares in Q1 2019, an estimated $199K.
  • Aerie Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1375 holding.
  • TIAA CREF Investment Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and has held it in 22 quarters since.
  • TIAA CREF Investment Management's Aerie Pharmaceuticals position peaked at $7.62M in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.